5 results
2 - Trump in the Land of OZ: Pathologizing Hillary Clinton and the Feminine Body
- Edited by Christine A. Kray, Tamar W. Carroll, Hinda Mandell
-
- Book:
- Nasty Women and Bad Hombres
- Published by:
- Boydell & Brewer
- Published online:
- 02 June 2021
- Print publication:
- 10 October 2018, pp 42-59
-
- Chapter
- Export citation
-
Summary
Disclosure of a candidate's medical history has become de rigueur in presidential campaigns, a mundane ritual since Thomas Eagleton's history of psychiatric treatment sank his vice presidential bid in 1972. The 2016 presidential election redramatized the issue of health. Hillary Clinton's physician had provided a written health assessment on July 28, 2015. That two-page letter discussed her well-publicized concussion incurred while secretary of state, seasonal allergies, a list of medications, and the lab results from a March 2015 checkup. The letter attested that she was “a healthy female” with “a healthy lifestyle,” and that a “full medical evaluation” shows her “in excellent physical condition and fit to serve as President of the United States.” Her sudden illness in September 2016 raised questions about the health of both major parties’ candidates, as Donald Trump remained evasive about his own health status.
Prior to that, the sole official assessment of Donald Trump's health had consisted of a fourteen-line letter dated December 4, 2015, referencing “a recent [undated] complete medical examination that showed only positive results.” The “laboratory test results [quantifying only blood pressure] were astonishingly excellent.” Trump was taking a low-dose aspirin and an unspecified dosage of an unspecified statin daily. The letter concluded: “If selected, Mr. Trump, I can state unequivocally, will be the healthiest individual ever selected to the presidency.” This onslaught of vague superlatives raised suspicions, which increased when the physician admitted to writing the letter in a few minutes without proofreading it.
On September 11, 2016, Hillary Clinton attended a ceremony in New York commemorating the fifteenth anniversary of the 9/11 terrorist attacks. She abruptly departed during the ceremony, staggering and needing physical assistance to return to her vehicle. The extensively aired video footage ignited speculations about the candidate's health. After initially claiming she was simply faint from hyperthermia, her campaign eventually disclosed that she had been diagnosed with pneumonia two days before the event—a fact unknown by many of her own staff. Her physician prescribed complete rest (a veritable “rest cure”), and Clinton vanished entirely from the campaign trail for three days.
Contributors
-
- By Nic Beech, Chris Bilton, Alan Bradshaw, Stephen Broad, Shiona Chillas, Martin Cloonan, Kevina Cody, Christine Coupland, Stephen Cummings, Ann Cunliffe, Chris Cusack, Jane Donald, Martin Dowling, Michael Downes, Celia Duffy, Charlotte Gilmore, Lance Green, Gail Greig, Elizabeth Gulledge, Chris Hackley, Martin John Henry, Paul Hibbert, Casper Hoedemaekers, R. M. Hubbert, John Hunt, Peter Keenan, Nod Knowles, Gretchen Larsen, Johnny Lynch, Raymond MacDonald, Robert MacIntosh, Katy MacKintosh, Donald MacLean, Katy J. Mason, Alan McCusker-Thompson, Lloyd Meredith, Louise Mitchell, Davide Nicolini, Daragh O’Reilly, Jill O’Sullivan, Cliff Oswick, Marco Panagopoulos, Jim Prime, Jenny Reeve, Simon Rose, Michael Saren, David Sims, Ian Smith, Duglas T. Stewart, Chris Stout, Dimitrinka Stoyanova Russell, Antonio Strati, Ben Talbot Dunn:, Robyn Thomas, Lori Watson, Simon Webb, Richard Wigley, Sierk Ybema, Matthew Young, Carlo Zanotti
- Edited by Nic Beech, University of Dundee, Charlotte Gilmore, University of Edinburgh
-
- Book:
- Organising Music
- Published online:
- 05 January 2015
- Print publication:
- 05 February 2015, pp xii-xxviii
-
- Chapter
- Export citation
Notes on Contributors
-
- By David Amigoni, Mark Asquith, Jane Bownas, Adelene Buckland, Carolyn Burdett, Pamela Dalziel, Christine DeVine, Tim Dolin, Roger Ebbatson, Trish Ferguson, Shanyn Fiske, Simon Gatrell, Sophie Gilmartin, William Greenslade, Ann Heilmann, Michael Herbert, John Hughes, Rena Jackson, Elizabeth Langland, Sarah E. Maier, Phillip Mallett, Francesco Marroni, Jane Mattisson, Andrew Nash, K. M. Newton, Francis O’Gorman, John Osborne, Patrick Parrinder, Andrew Radford, Fred Reid, Angelique Richardson, Mary Rimmer, Peter Robinson, Dennis Taylor, Jenny Bourne, Jane Thomas, Herbert F. Tucker, Norman Vance, Roger Webster, Rebecca Welshman, Glen Wickens, Melanie Williams, Keith Wilson, T. R. Wright
- Edited by Phillip Mallett, University of St Andrews, Scotland
-
- Book:
- Thomas Hardy in Context
- Published online:
- 05 February 2013
- Print publication:
- 18 March 2013, pp ix-xvi
-
- Chapter
- Export citation
Genome-Wide Association Study for Ovarian Cancer Susceptibility Using Pooled DNA
- Yi Lu, Xiaoqing Chen, Jonathan Beesley, Sharon E. Johnatty, Anna deFazio, Australian Ovarian Cancer Study (AOCS) Study Group, Sandrina Lambrechts, Diether Lambrechts, Evelyn Despierre, Ignace Vergotes, Jenny Chang-Claude, Rebecca Hein, Stefan Nickels, Shan Wang-Gohrke, Thilo Dörk, Matthias Dürst, Natalia Antonenkova, Natalia Bogdanova, Marc T. Goodman, Galina Lurie, Lynne R. Wilkens, Michael E. Carney, Ralf Butzow, Heli Nevanlinna, Tuomas Heikkinen, Arto Leminen, Lambertus A. Kiemeney, Leon F.A.G. Massuger, Anne M. van Altena, Katja K. Aben, Susanne Krüger Kjaer, Estrid Høgdall, Allan Jensen, Angela Brooks-Wilson, Nhu Le, Linda Cook, Madalene Earp, Linda Kelemen, Douglas Easton, Paul Pharoah, Honglin Song, Jonathan Tyrer, Susan Ramus, Usha Menon, Alexandra Gentry-Maharaj, Simon A. Gayther, Elisa V. Bandera, Sara H. Olson, Irene Orlow, Lorna Rodriguez-Rodriguez, Stuart Macgregor, Georgia Chenevix-Trench
-
- Journal:
- Twin Research and Human Genetics / Volume 15 / Issue 5 / October 2012
- Published online by Cambridge University Press:
- 13 July 2012, pp. 615-623
-
- Article
-
- You have access Access
- HTML
- Export citation
-
Recent Genome-Wide Association Studies (GWAS) have identified four low-penetrance ovarian cancer susceptibility loci. We hypothesized that further moderate- or low-penetrance variants exist among the subset of single-nucleotide polymorphisms (SNPs) not well tagged by the genotyping arrays used in the previous studies, which would account for some of the remaining risk. We therefore conducted a time- and cost-effective stage 1 GWAS on 342 invasive serous cases and 643 controls genotyped on pooled DNA using the high-density Illumina 1M-Duo array. We followed up 20 of the most significantly associated SNPs, which are not well tagged by the lower density arrays used by the published GWAS, and genotyping them on individual DNA. Most of the top 20 SNPs were clearly validated by individually genotyping the samples used in the pools. However, none of the 20 SNPs replicated when tested for association in a much larger stage 2 set of 4,651 cases and 6,966 controls from the Ovarian Cancer Association Consortium. Given that most of the top 20 SNPs from pooling were validated in the same samples by individual genotyping, the lack of replication is likely to be due to the relatively small sample size in our stage 1 GWAS rather than due to problems with the pooling approach. We conclude that there are unlikely to be any moderate or large effects on ovarian cancer risk untagged by less dense arrays. However, our study lacked power to make clear statements on the existence of hitherto untagged small-effect variants.
Contributors
-
- By Douglas L. Arnold, Laura J. Balcer, Amit Bar-Or, Sergio E. Baranzini, Frederik Barkhof, Robert A. Bermel, Francois A. Bethoux, Dennis N. Bourdette, Richard K. Burt, Peter A. Calabresi, Zografos Caramanos, Tanuja Chitnis, Stacey S. Cofield, Jeffrey A. Cohen, Nadine Cohen, Alasdair J. Coles, Devon Conway, Stuart D. Cook, Gary R. Cutter, Peter J. Darlington, Ann Dodds-Frerichs, Ranjan Dutta, Gilles Edan, Michelle Fabian, Franz Fazekas, Massimo Filippi, Elizabeth Fisher, Paulo Fontoura, Corey C. Ford, Robert J. Fox, Natasha Frost, Alex Z. Fu, Siegrid Fuchs, Kazuo Fujihara, Kristin M. Galetta, Jeroen J.G. Geurts, Gavin Giovannoni, Nada Gligorov, Ralf Gold, Andrew D. Goodman, Myla D. Goldman, Jenny Guerre, Stephen L. Hauser, Peter B. Imrey, Douglas R. Jeffery, Stephen E. Jones, Adam I. Kaplin, Michael W. Kattan, B. Mark Keegan, Kyle C. Kern, Zhaleh Khaleeli, Samia J. Khoury, Joep Killestein, Soo Hyun Kim, R. Philip Kinkel, Stephen C. Krieger, Lauren B. Krupp, Emmanuelle Le Page, David Leppert, Scott Litwiller, Fred D. Lublin, Henry F. McFarland, Joseph C. McGowan, Don Mahad, Jahangir Maleki, Ruth Ann Marrie, Paul M. Matthews, Francesca Milanetti, Aaron E. Miller, Deborah M. Miller, Xavier Montalban, Charity J. Morgan, Ichiro Nakashima, Sridar Narayanan, Avindra Nath, Paul W. O’Connor, Jorge R. Oksenberg, A. John Petkau, Michael D. Phillips, J. Theodore Phillips, Tammy Phinney, Sean J. Pittock, Sarah M. Planchon, Chris H. Polman, Alexander Rae-Grant, Stephen M. Rao, Stephen C. Reingold, Maria A. Rocca, Richard A. Rudick, Amber R. Salter, Paula Sandler, Jaume Sastre-Garriga, John R. Scagnelli, Dana J. Serafin, Lynne Shinto, Nancy L. Sicotte, Jack H. Simon, Per Soelberg Sørensen, Ryan E. Stagg, James M. Stankiewicz, Lael A. Stone, Amy Sullivan, Matthew Sutliff, Jessica Szpak, Alan J. Thompson, Bruce D. Trapp, Helen Tremlett, Maria Trojano, Orla Tuohy, Rhonda R. Voskuhl, Marc K. Walton, Mike P. Wattjes, Emmanuelle Waubant, Martin S. Weber, Howard L Weiner, Brian G. Weinshenker, Bianca Weinstock-Guttman, Jeffrey L. Winters, Jerry S. Wolinsky, Vijayshree Yadav, E. Ann Yeh, Scott S. Zamvil
- Edited by Jeffrey A. Cohen, Richard A. Rudick
-
- Book:
- Multiple Sclerosis Therapeutics
- Published online:
- 05 December 2011
- Print publication:
- 20 October 2011, pp viii-xii
-
- Chapter
- Export citation